Literature DB >> 12663411

Setting up an outcomes guarantee for pharmaceuticals: new approach to risk sharing in primary care.

Stephen Chapman1, Elly Reeve, Giri Rajaratnam, Richard Neary.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12663411      PMCID: PMC1125604          DOI: 10.1136/bmj.326.7391.707

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  3 in total

1.  Health department to fund interferon beta despite institute's ruling.

Authors:  S Mayor
Journal:  BMJ       Date:  2001-11-10

2.  Funding medicines for people with multiple sclerosis.

Authors:  D Taylor
Journal:  BMJ       Date:  2001-12-15

3.  NHS to fund treatment for 10000 patients with MS.

Authors:  Ruth Little
Journal:  BMJ       Date:  2002-02-09
  3 in total
  8 in total

1.  Rationing of drugs for rare diseases.

Authors:  Dyfrig Hughes
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Can't get no satisfaction? Will pay for performance help?: toward an economic framework for understanding performance-based risk-sharing agreements for innovative medical products.

Authors:  Adrian Towse; Louis P Garrison
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

3.  Access with evidence development schemes: a framework for description and evaluation.

Authors:  Christopher J McCabe; Tania Stafinski; Richard Edlin; Devidas Menon
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 4.  Funding the unfundable: mechanisms for managing uncertainty in decisions on the introduction of new and innovative technologies into healthcare systems.

Authors:  Tania Stafinski; Christopher J McCabe; Devidas Menon
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 5.  Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.

Authors:  Jakub Adamski; Brian Godman; Gabriella Ofierska-Sujkowska; Bogusława Osińska; Harald Herholz; Kamila Wendykowska; Ott Laius; Saira Jan; Catherine Sermet; Corrine Zara; Marija Kalaba; Roland Gustafsson; Kristina Garuolienè; Alan Haycox; Silvio Garattini; Lars L Gustafsson
Journal:  BMC Health Serv Res       Date:  2010-06-07       Impact factor: 2.655

6.  Drug approval status and recommendations for listing on public formularies: a Canadian cohort analysis.

Authors:  Joel Lexchin
Journal:  BMJ Open       Date:  2017-10-22       Impact factor: 2.692

Review 7.  Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends.

Authors:  Trevor Jozef Piatkiewicz; Janine Marie Traulsen; Tove Holm-Larsen
Journal:  Pharmacoecon Open       Date:  2018-06

8.  Multiple sclerosis risk sharing scheme: two year results of clinical cohort study with historical comparator.

Authors:  Mike Boggild; Jackie Palace; Pelham Barton; Yoav Ben-Shlomo; Thomas Bregenzer; Charles Dobson; Richard Gray
Journal:  BMJ       Date:  2009-12-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.